SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-098753
Filing Date
2017-03-28
Accepted
2017-03-28 08:17:25
Documents
69
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d314087d10k.htm 10-K 787446
2 EX-21.1 d314087dex211.htm EX-21.1 2416
3 EX-23.1 d314087dex231.htm EX-23.1 2582
4 EX-31.1 d314087dex311.htm EX-31.1 9367
5 EX-31.2 d314087dex312.htm EX-31.2 9358
6 EX-32.1 d314087dex321.htm EX-32.1 4271
7 EX-32.2 d314087dex322.htm EX-32.2 4120
  Complete submission text file 0001193125-17-098753.txt   5538252

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT galt-20161231.xml EX-101.INS 844933
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20161231.xsd EX-101.SCH 71584
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20161231_cal.xml EX-101.CAL 45829
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20161231_def.xml EX-101.DEF 388261
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20161231_lab.xml EX-101.LAB 535666
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20161231_pre.xml EX-101.PRE 452050
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 17716840
SIC: 2834 Pharmaceutical Preparations